SSgA SPDR ETFs Europe II Plc - S&P US Health Care Sel. Sec. UCITS ETF Accum Ptg USD (SSEHF) Latest News, Market Updates & Sentiment | Edgen
Back
Home
Stock
SSEHF
SSgA SPDR ETFs Europe II Plc - S&P US Health Care Sel. Sec. UCITS ETF Accum Ptg USD (SSEHF)
SSEHF Stock Price Chart
SSEHF
SSgA SPDR ETFs Europe II Plc - S&P US Health Care Sel. Sec. UCITS ETF Accum Ptg USD
$45.22
-2.09%
$-0.96
At close: Mar 25, 16:00:00 GMT-4
$45.22
0%
$0
Pre-market: Mar 26, 06:55:57 GMT-4
Overview
Forecast
Holdings
News
Key Stats
Prev.Close
$46.19
Open
$45.22
Day's Range
$45.22 - $45.22
52 week range
$39.35 - $49.03
Volume
--
Avg.Volume
3.3K
Dividend yield
--
Net Assets
$0
NAV
--
Expense Ratio
--
Shares Outstanding
11.8M
What is SSEHF?
ZPDH.DE was created on 2015-07-07 by SPDR. The fund's investment portfolio concentrates primarily on health care equity. The objective of the Fund is to track the performance of large sized U.S. health care companies in the S&P 500 Index.
Features
AI Copilot for Stock & Crypto
Price Prediction
Fundraise Tracker
Themes
Crypto Comparison
Home Page
Resources
Tutorial
Gitbook
Team
Aura Insights
Market
US Market
HK Market
Crypto Market
Terms of Use
Privacy Policy
Sitemap
© 2026 Finture Development Limited. All rights reserved
Innovent Rises 3% as Eli Lilly Pact Finalizes
Mar 25 2026, 01:51
Merck Nears $6 Billion All-Cash Deal for Terns Pharma
Mar 25 2026, 01:41
Gilead Advances Talks to Acquire Ouro Medicines
Mar 23 2026, 16:52
TuHURA Hires JNJ Veteran Behind $16B Drugs for Cancer Push
Mar 23 2026, 12:06
Abbott Finalizes Exact Sciences Acquisition to Lead Cancer Diagnostics
Mar 20 2026, 13:39
AbbVie Stock Falls 5% as FDA Approves J&J's Rival Psoriasis Pill
Mar 19 2026, 13:42
Eli Lilly's Retatrutide Delivers 17% Weight Loss in Diabetes Trial
Mar 19 2026, 11:15
Roche Targets Obesity Market, Escalating Rivalry with Lilly and Novo
Mar 19 2026, 08:11
Johnson & Johnson Secures FDA Approval for Oral Psoriasis Drug
Mar 18 2026, 12:07
UnitedHealth Targets 7.2M Members With Doula Coverage to Cut Costs
Mar 17 2026, 16:56
Eli Lilly Stock Slides 5% on Obesity Drug Market Warning
Mar 17 2026, 16:34
Intuitive Surgical Projects Da Vinci Slowdown for 2026
Mar 12 2026, 04:58
Pharmaron Stock Climbs 12.6% on $200M Eli Lilly GLP-1 Deal
Mar 12 2026, 02:58
Eli Lilly Commits $3 Billion to China for Obesity Drug Production
Mar 11 2026, 10:00
UnitedHealth Stock Falters Under Regulatory and Cost Pressures
Mar 09 2026, 16:34
FDA Approves J&J, Halozyme Myeloma Combination Therapy
Mar 06 2026, 13:28
Eli Lilly Stock Slides 5% as Obesity Drug Competition Intensifies
Mar 05 2026, 14:34
Lilly Bypasses Insurers With Direct-to-Employer Zepbound Platform
Mar 05 2026, 11:27